D. Scollard

发表

Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo.

Jean-Philippe Pignol, Humphrey Fonge, J. Pignol, 2012, Molecular pharmaceutics.

99mTc-Sestamibi, A Sensitive Probe for In Vivo Imaging of P-Glycoprotein Inhibition by Modulators and mdr1 Antisense Oligodeoxynucleotides

Jing-Hung Wang, R. Reilly, M. Piquette-Miller, 2006, Molecular Imaging and Biology.

In vitro and in vivo evaluation of WK‐X‐34, a novel inhibitor of P‐glycoprotein and BCRP, using radio imaging techniques

R. Reilly, M. Piquette-Miller, M. Wiese, 2006, International journal of cancer.

Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts Downregulation and Tumor Response in Athymic HER 2 Trastuzumab-Mediated In-DTPA-Pertuzumab Sensitively Detects 111 Micro-SPECT / CT with

B. Cornelissen, R. Reilly, Zhongli Cai, 2009 .

The Necrosis-Avid Small Molecule HQ4-DTPA as a Multimodal Imaging Agent for Monitoring Radiation Therapy-Induced Tumor Cell Death

R. Dacosta, T. Snoeks, C. Löwik, 2016, Front. Oncol..

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

G. Lockwood, B. Cornelissen, C. Caldwell, 2014, American journal of nuclear medicine and molecular imaging.

Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer

R. Reilly, Conrad Chan, Meiduo Hu, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT

R. Reilly, Conrad Chan, K. McLarty, 2011, EJNMMI research.

123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21WAF-1/Cip-1

R. Reilly, K. Vallis, Meiduo Hu, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.

B. Cornelissen, V. Kersemans, R. Reilly, 2008, Nuclear medicine and biology.

A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer.

R. Reilly, C. Holloway, Conrad Chan, 2011, Nuclear medicine and biology.

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

Bart Cornelissen, Deborah A. Scollard, Susan J. Done, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Pertuzumab Sensitively Detects Trastuzumab- Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA- MB-361 Human Breast Cancer Xenografts

B. Cornelissen, R. Reilly, Zhongli Cai, 2009 .

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.

R. Cameron, R. Reilly, K. Vallis, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.

R. Reilly, Conrad Chan, K. Vallis, 2007, Nuclear medicine and biology.

A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.

R. Reilly, L. Henderson, K. Vallis, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging.

Jing-Hung Wang, R. Reilly, S. Teng, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates

R. Reilly, D. Scollard, Eva J Razumienko, 2013, Breast Cancer Research and Treatment.

Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.

R. Reilly, C. Allen, H. Fonge, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.

R. Reilly, C. Holloway, H. Kahn, 2005, Nuclear medicine and biology.

Kit for the preparation of 111In-labeled pertuzumab injection for imaging response of HER2-positive breast cancer to trastuzumab (Herceptin).

M. Levine, R. Reilly, Conrad Chan, 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.

A. Guha, R. Reilly, Conrad Chan, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Micro-SPECT/CT with 111In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts

Bart Cornelissen, B. Cornelissen, R. Reilly, 2009, Journal of Nuclear Medicine.

Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis

R. Reilly, S. Acuna, D. Scollard, 2023, Molecular therapy oncolytics.

Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments

R. Reilly, C. Holloway, Judy S. Wang, 2005, Nuclear medicine communications.

Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide.

S. Libutti, J. Carrasquillo, D. Bartlett, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF

Katherine A Vallis, R. Reilly, Zhongli Cai, 2008, Journal of Nuclear Medicine.

64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents.

R. Reilly, D. Scollard, Luke Yongkyu Kwon, 2017, Molecular pharmaceutics.

Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.

J. Gariépy, R. Reilly, Shaoxian Yang, 2007, Bioconjugate chemistry.

Epidermal Growth Factor Receptor Inhibition Modulates the Nuclear Localization and Cytotoxicity of the Auger Electron–Emitting Radiopharmaceutical 111In-DTPA–Human Epidermal Growth Factor

Katherine A Vallis, R. Reilly, Zhongli Cai, 2007, Journal of Nuclear Medicine.

18F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice

R. Reilly, S. Done, D. Vines, 2009, Journal of Nuclear Medicine.

Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models

S. Baruchel, M. Ganguly, R. Vali, 2017, Contrast media & molecular imaging.

Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments.

C. Caldwell, L. Ehrlich, R. Reilly, 2013, Nuclear medicine and biology.

Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

R. Reilly, Raymond M Reilly, D. Scollard, 2012, The Journal of Nuclear Medicine.